Freestone Capital Holdings’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $184K | Hold |
20,000
| – | – | 0.01% | 430 |
|
|
2025
Q1 | $172K | Hold |
20,000
| – | – | 0.01% | 424 |
|
|
2024
Q4 | $215K | Hold |
20,000
| – | – | 0.01% | 413 |
|
|
2024
Q3 | $114K | Buy |
20,000
+6,200
| +45% | +$35.2K | ﹤0.01% | 416 |
|
|
2024
Q2 | $58.2K | Hold |
13,800
| – | – | ﹤0.01% | 446 |
|
|
2024
Q1 | $70.2K | Hold |
13,800
| – | – | ﹤0.01% | 430 |
|
|
2023
Q4 | $128K | Hold |
13,800
| – | – | 0.01% | 379 |
|
|
2023
Q3 | $90.4K | Buy |
13,800
+3,800
| +38% | +$24.9K | ﹤0.01% | 352 |
|
|
2023
Q2 | $81.3K | Buy |
+10,000
| New | +$81.3K | ﹤0.01% | 367 |
|